D-0070-2027 Class II Ongoing
FDA drug recall D-0070-2027 was initiated by Right Value Drug Stores LLC on Oct 9, 2026 and is designated Class II. Reason for recall: Lack of sterility assurance. The recall status is ongoing. Affected quantity: 4675 vials.
Recall details
- Product Type
- Drugs
- Report Date
- Oct 28, 2026
- Initiation Date
- Oct 9, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4675 vials
Product description
Testosterone Cypionate, 200 mg/mL, packaged in a) 5 mL vials (NDC 73271-1225-1) and b) 30 m vials ( NDC 73271-1226-2) This Is A Compounded Dug, Intramuscular Use, Office Use Only, 8400 Esters Blvd, STE 190, Irving, TX 75063.
Reason for recall
Lack of sterility assurance.
Distribution pattern
Nationwide in the USA.
Code information
a) Lot 10212025@3, BUD 10/21/2026; 10292025@4, BUD 10/29/2026; 10282025@6, BUD: 10/29/2026; 12012025@1, BUD: 12/01/2026; 04072026@1, BUD: 04/01/2027; 05262026@3, BUD 05/08/2027; 05262026@7, BUD 11/17/2026; 05272026@1, BUD 05/08/2027; 05272026@2, BUD: 11/22/2026; 07032026@1, BUD 05/08/2027; 07022026@1, BUD: 05/08/2027; 07062026@3, BUD: 05/08/2027; 07072026@3, BUD: 12/30/2026. b) 04012026@2, BUD 04/01/2027.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0070-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026